Clinical Trial

Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study

Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates the impact of calaspargase pegol (Cal-PEG) on the coagulation system in pediatric patients with acute lymphoblastic leukemia/lymphoma (ALL).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-16; most recent amendment 2026-02-11.
Status change: Not Yet Recruiting → Recruiting 2025-09-10
Trial Details
NCT Number NCT07071051
Lead Sponsor Mayo Clinic
Conditions Childhood Acute Lymphoblastic Leukemia, Childhood Lymphoblastic Lymphoma
Enrollment 15 participants
Start Date 2025-07-31
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-13